Elanco Animal Health
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $11.75
- Today's High:
- $12.04
- Open Price:
- $11.79
- 52W Low:
- $7.88
- 52W High:
- $24.83
- Prev. Close:
- $11.78
- Volume:
- 4644663
Company Statistics
- Market Cap.:
- $4.49 billion
- Book Value:
- 15.19
- Revenue TTM:
- $4.44 billion
- Operating Margin TTM:
- 9.79%
- Gross Profit TTM:
- $2.50 billion
- Profit Margin:
- -0.59%
- Return on Assets TTM:
- 1.7%
- Return on Equity TTM:
- -0.34%
Company Profile
Elanco Animal Health had its IPO on 2018-09-20 under the ticker symbol ELAN.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Elanco Animal Health has a staff strength of 9,000 employees.
Stock update
Shares of Elanco Animal Health opened at $11.79 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $11.75 - $12.04, and closed at $11.98.
This is a +1.7% increase from the previous day's closing price.
A total volume of 4,644,663 shares were traded at the close of the day’s session.
In the last one week, shares of Elanco Animal Health have slipped by -3.31%.
Elanco Animal Health's Key Ratios
Elanco Animal Health has a market cap of $4.49 billion, indicating a price to book ratio of 0.8999 and a price to sales ratio of 1.2755.
In the last 12-months Elanco Animal Health’s revenue was $4.44 billion with a gross profit of $2.50 billion and an EBITDA of $1.05 billion. The EBITDA ratio measures Elanco Animal Health's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Elanco Animal Health’s operating margin was 9.79% while its return on assets stood at 1.7% with a return of equity of -0.34%.
In Q1, Elanco Animal Health’s quarterly earnings growth was a positive 109.7% while revenue growth was a positive 2.5%.
Elanco Animal Health’s PE and PEG Ratio
- Forward PE
- 10.2354
- Trailing PE
- 0
- PEG
- 1.8448
Its diluted EPS in the last 12-months stands at $-0.06 per share while it has a forward price to earnings multiple of 10.2354 and a PEG multiple of 1.8448. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Elanco Animal Health’s profitability.
Elanco Animal Health stock is trading at a EV to sales ratio of 2.5338 and a EV to EBITDA ratio of 14.1759. Its price to sales ratio in the trailing 12-months stood at 1.2755.
Elanco Animal Health stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $15.77 billion
- Total Liabilities
- $1.58 billion
- Operating Cash Flow
- $-55000000.00
- Capital Expenditure
- $20 million
- Dividend Payout Ratio
- 0%
Elanco Animal Health ended 2024 with $15.77 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $15.77 billion while shareholder equity stood at $7.48 billion.
Elanco Animal Health ended 2024 with $0 in deferred long-term liabilities, $1.58 billion in other current liabilities, in common stock, $-954000000.00 in retained earnings and $6.06 billion in goodwill. Its cash balance stood at $318.00 million and cash and short-term investments were $318.00 million. The company’s total short-term debt was $381,000,000 while long-term debt stood at $0.
Elanco Animal Health’s total current assets stands at $3.55 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $1.05 billion compared to accounts payable of $381.00 million and inventory worth $1.60 billion.
In 2024, Elanco Animal Health's operating cash flow was $-55000000.00 while its capital expenditure stood at $20 million.
Comparatively, Elanco Animal Health paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $11.98
- 52-Week High
- $24.83
- 52-Week Low
- $7.88
- Analyst Target Price
- $13.21
Elanco Animal Health stock is currently trading at $11.98 per share. It touched a 52-week high of $24.83 and a 52-week low of $24.83. Analysts tracking the stock have a 12-month average target price of $13.21.
Its 50-day moving average was $11.64 and 200-day moving average was $11.05 The short ratio stood at 1.22 indicating a short percent outstanding of 0%.
Around 52.6% of the company’s stock are held by insiders while 10029.2% are held by institutions.
Frequently Asked Questions About Elanco Animal Health
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. The company was founded in 1954 and is headquartered in Greenfield, Indiana.